Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines.
Sabine VoglerNina ZimmermannManuel Alexander HaasisVerena KnollJaime EspinAukje K Mantel-TeeuwisseDimitra PanteliFatima SulemanVeronika J WirtzZaheer Ud-Din BabaarPublished in: Journal of pharmaceutical policy and practice (2024)
Sustainable access to affordable medicines remains a public health issue globally, including for high-income countries. To foster the debate on avenues for the future, the fifth PPRI Conference held in Vienna on 25 and 26 April 2024 will offer a forum for the debate on innovating pharmaceutical policymaking to develop and implement futureproof policy options, which are able to address current and future challenges. The Conference invites a broad audience of stakeholders, including researchers, policymakers, payers, patients, industry and health professionals. The conference topics are organised in three strands: Strand 1 on 'Local challenges, global learnings' aims to contribute to lively discussions on the implementation of pharmaceutical policies across the globe. Best-practice examples will be presented, supplemented by case studies of less effective policies which can offer rich learnings. Strand 2 on 'Strengthening the evidence base' is the place for presentations and discussions on topics such as health technology assessments, managed entry agreements and real-world data. Strand 3 'Futureproofing pharmaceutical policies' is particularly dedicated to explore innovation in policymaking to achieve sustainable access to affordable medicines.
Keyphrases
- public health
- healthcare
- end stage renal disease
- primary care
- global health
- chronic kidney disease
- current status
- newly diagnosed
- ejection fraction
- mental health
- quality improvement
- electronic health record
- big data
- risk assessment
- peritoneal dialysis
- climate change
- social media
- artificial intelligence
- data analysis
- patient reported